The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Mapping of a major genetic modifier of embryonic lethality in TGFβ1 knockout mice
Abstract
The transforming growth factor beta 1 (TGF beta 1) signalling pathway is important in embryogenesis and has been implicated in hereditary haemorrhagic telangiectasia (HHT), atherosclerosis, tumorigenesis and immunomodulation. Therefore, identification of factors which modulate TGF beta 1 bioactivity in vivo is important. On a mixed genetic background, approximately 50% Tgfb1-/- conceptuses die midgestation from defective yolk sac vasculogenesis. The other half are developmentally normal but die three weeks postpartum. Intriguingly, the vascular defects of Tgfb1-/- mice share histological similarities to lesions seen in HHT patients. It has been suggested that dichotomy in Tgfb1-/- lethal phenotypes is due to maternal TGF beta 1 rescue of some, but not all, Tgfb1-/- embryos12. Here we show that the Tgfb1-/- phenotype depends on the genetic background of the conceptus. In NIH/Ola, C57BL/6J/Ola and F1 conceptuses, Tgfb1-/- lethality can be categorized into three developmental classes. A major codominant modifier gene of embryo lethality was mapped to proximal mouse chromosome 5, using a genome scan for non-mendelian distribution of alleles in Tgfb1-/- neonatal animals which survive prenatal lethality. This gene accounts for around three quarters of the genetic effect between mouse strains and can, in part, explain the distribution of the three lethal phenotypes. This approach, using neonatal DNA samples, is generally applicable to identification of loci that influence the effect of early embryonic lethal mutations, thus furthering knowledge of genetic interactions that occur during early mammalian development in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“preclinical studies highlight extensive influences of germline genetic modifiers of TGF-β activity on tumorigenesis, vascular integrity and allergy392,398–400.”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [399]
Citations
Cites
Lander, E. S., Green, P., Abrahamson, J., Barlow, A., Daly, M. J., Lincoln, S. E., & Newberg, L. A. (1987) · Genomics · doi:10.1016/0888-7543(87)90010-3 · Cited by 6,657
Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results
Lander, E. S., & Kruglyak, L. (1995) · Nature Genetics · doi:10.1038/ng1195-241 · Cited by 5,236
Genetic Dissection of Complex Traits
Lander, E. S., & Schork, N. J. (1994) · Science · doi:10.1126/science.8091226 · Cited by 3,425
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Liu, J.-P., Baker, J. C., Perkins, A. S., Robertson, E. J., & Efstratiadis, A. (1993) · Cell · doi:10.1016/s0092-8674(05)80084-4 · Cited by 2,854
Inactivation of the Type II TGF-β Receptor in Colon Cancer Cells with Microsatellite Instability
Markowitz, S. D., Wang, J., Myeroff, L. L., Parsons, R. E., Sun, L., Lutterbaugh, J., Fan, R. S., Zborowska, E., Kinzler, K. W., Vogelstein, B., et al. (1995) · Science · doi:10.1126/science.7761852 · Cited by 2,267
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
McAllister, K. A., Grogg, K. M., Johnson, D. W., Gallione, C. J., Baldwin, M. A., Jackson, C. E., Helmbold, E. A., Markel, D. S., McKinnon, W. C., Murrel, J., et al. (1994) · Nature Genetics · doi:10.1038/ng1294-345 · Cited by 1,475
Defects in mesoderm, neural tube and vascular development in mouse embryos lacking fibronectin
George, E. L., Georges‐Labouesse, E., Patel, R., Rayburn, H., & Hynes, R. O. (1993) · Development · doi:10.1242/dev.119.4.1079 · Cited by 1,305
Targeted Disruption of Mouse EGF receptor: Effect of Genetic Background on Mutant Phenotype
Threadgill, D. W., Dlugosz, A. A., Hansen, L. A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R. C., et al. (1995) · Science · doi:10.1126/science.7618084 · Cited by 1,179
Cited by
Sorted by citations
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
Self-citationTGFβ biology in cancer progression and immunotherapy
Derynck, R., Turley, S. J., & Akhurst, R. J. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0403-1 · Cited by 944
Self-citationTransforming growth factor-beta: Vasculogenesis, angiogenesis, and vessel wall integrity
Pepper, M. S. (1997) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(96)00048-2 · Cited by 737
Kyriakides, T. R., Zhu, Y.-H., Smith, L. T., Bain, S. D., Yang, Z., Lin, M. T., Danielson, K. G., Iozzo, R. V., LaMarca, M. E., McKinney, C. E., et al. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.419 · Cited by 503
Arthur, H. M., Ure, J. M., Smith, A. J. H., Renforth, G. L., Wilson, D. I., Torsney, E., Charlton, R., Parums, D. V., Jowett, T., Marchuk, D. A., et al. (2000) · Developmental Biology · doi:10.1006/dbio.1999.9534 · Cited by 448
Raballo, R., Rhee, J., Lyn-Cook, R., Leckman, J. F., Schwartz, M. L., & Vaccarino, F. M. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-13-05012.2000 · Cited by 421
Fedde, K. N., Blair, L. A., Silverstein, J. M., Coburn, S. P., Ryan, L. M., Weinstein, R. S., Waymire, K. G., Narisawa, S., Millán, J. L., MacGregor, G. R., et al. (1999) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1999.14.12.2015 · Cited by 409
Functional analysis of the TGFbeta receptor/Smad pathway through gene ablation in mice
Goumans, M., & Mummery, C. L. (2000) · The International Journal of Developmental Biology · doi:10.1387/ijdb.10853822 · Cited by 376
Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain
Brionne, T. C., Tesseur, I., Masliah, E., & Wyss-Coray, T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00766-9 · Cited by 367
TGF-β Signaling in Control of Cardiovascular Function
Goumans, M.-J., & ten Dijke, P. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022210 · Cited by 360
Basement membrane and blood–brain barrier
Xu, L., Nirwane, A. M., & Yao, Y. (2018) · Stroke and Vascular Neurology · doi:10.1136/svn-2018-000198 · Cited by 386
Transforming growth factor‐β and Smad signalling in kidney diseases
WANG, W., Koka, V., & Lan, H. Y. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00334.x · Cited by 347
A reference human induced pluripotent stem cell line for large-scale collaborative studies
Pantazis, C. B., Yang, A., Lara, E., McDonough, J. A., Blauwendraat, C., Peng, L., Oguro, H., Kanaujiya, J., Zou, J., Sebesta, D., et al. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2022.11.004 · Cited by 310
Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis
Müller, U. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00021-0 · Cited by 269
Relative roles of TGF‐β1 and Wnt in the systemic regulation and aging of satellite cell responses
Carlson, M. E., Conboy, M. J., Hsu, M., Barchas, L., Jeong, J., Agrawal, A., Mikels, A. J., Agrawal, S., Schaffer, D. V., & Conboy, I. M. (2009) · Aging Cell · doi:10.1111/j.1474-9726.2009.00517.x · Cited by 244
Targeting TGF-β Signaling for Therapeutic GainPreprint
Akhurst, R. J. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a022301 · Cited by 255
Self-citationProminent role of TGF-β1 in thrombopoietin-induced myelofibrosis in mice
Chagraoui, H., Komura, E., Tulliez, M., Giraudier, S., Vainchenker, W., & Wendling, F. (2002) · Blood · doi:10.1182/blood-2002-04-1133 · Cited by 238
Influence of Genetic Background on Genetically Engineered Mouse Phenotypes
Doetschman, T. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-471-1_23 · Cited by 233
Taipale, J., Saharinen, J., & Keski‐Oja, J. (1998) · Advances in cancer research · doi:10.1016/s0065-230x(08)60740-x · Cited by 209
The embryonic origins of erythropoiesis in mammals
Baron, M. H., Isern, J., & Fraser, S. T. (2012) · Blood · doi:10.1182/blood-2012-01-153486 · Cited by 209
Casademunt, E., Carter, B. D., Benzel, I. M., Frade, J. M., Dechant, G., & Barde, Y. (1999) · The EMBO Journal · doi:10.1093/emboj/18.21.6050 · Cited by 189
Basics of TGF-ß and Pancreatic Cancer
Truty, M. J., & Urrutia, R. A. (2007) · Pancreatology · doi:10.1159/000108959 · Cited by 192
Strain-dependent embryonic lethality in mice lacking the retinoblastoma-related p130 gene
LeCouter, J. E., Kablar, B., Whyte, P., Ying, C., & Rudnicki, M. A. (1998) · Development · doi:10.1242/dev.125.23.4669 · Cited by 181
Gomez, D. A., Zen, A. A. H., Borges, L. D. F., Philippe, M., Gutierrez, P. S., Jondeau, G., Michel, J., & Vranckx, R. (2009) · The Journal of Pathology · doi:10.1002/path.2516 · Cited by 178
Functions of mammalian Smad genes as revealed by targeted gene disruption in mice
Weinstein, M., Yang, X. Y., & Deng, C. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00028-3 · Cited by 173
Chimeric Mice with Humanized Liver: Tools for the Study of Drug Metabolism, Excretion, and Toxicity
Strom, S. C., Davila, J., & Grompe, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-688-7_27 · Cited by 161
Osteopontin regulates dentin and alveolar bone development and mineralization
Foster, B. L., Ao, M., Salmon, C. R., Chavez, M. B., Kolli, T. N., Tran, A. B., Chu, E. Y., Kantovitz, K. R., Yadav, M. C., Narisawa, S., et al. (2017) · Bone · doi:10.1016/j.bone.2017.12.004 · Cited by 155
ahr null alleles: distinctive or different?
Lahvis, G. P., & Bradfield, C. A. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(98)00134-8 · Cited by 152
Weinstein, M. B., Monga, S. P., Liu, Y., Brodie, S. G., Tang, Y., Li, C., Mishra, L., & Deng, C. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.15.5122-5131.2001 · Cited by 143
The role of pericytic laminin in blood brain barrier integrity maintenance
Gautam, J., Zhang, X., & Yao, Y. (2016) · Scientific Reports · doi:10.1038/srep36450 · Cited by 144
LeCouter, J. E., Kablar, B., Hardy, W. R., Ying, C., Megeney, L. A., May, L. L., & Rudnicki, M. A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.12.7455 · Cited by 142
Essential function of HIPK2 in TGFβ-dependent survival of midbrain dopamine neurons
Zhang, J., Pho, V., Bonasera, S. J., Holtzman, J., Tang, A. T., Hellmuth, J. M., Tang, S., Janak, P. H., Tecott, L. H., & Huang, E. J. (2006) · Nature Neuroscience · doi:10.1038/nn1816 · Cited by 135
Transforming growth factor β (TGF-β) and autoimmunity
Aoki, C. A., Borchers, A. T., Li, M. O., Flavell, R. A., Bowlus, C. L., Ansari, A. A., & Gershwin, M. E. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.03.006 · Cited by 123
Tranguch, S., Wang, H., Daikoku, T., Xie, H., Smith, D. F., & Dey, S. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31622 · Cited by 121
Yoon, J.-H., Sudo, K., Kuroda, M., Kato, M., Lee, I., Han, J. S., Nakae, S., Imamura, T., Kim, J., Ju, J. H., et al. (2015) · Nature Communications · doi:10.1038/ncomms8600 · Cited by 125
Molecular Basis of Vascular Anomalies
Vikkula, M. (1998) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(98)00024-3 · Cited by 119
Wang, H., Ma, W.-G., Tejada, L. V., Zhang, H., Morrow, J. D., Das, S. K., & Dey, S. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312203200 · Cited by 120
McCartney-Francis, N. L., Frazier-Jessen, M. R., & Wahl, S. M. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043009 · Cited by 117
Takeuchi, T., Kojima, M., Nakajima, K., & Kondo, S. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00100-8 · Cited by 114
Rı́us, C., Smith, J. D., Almendro, N., Langa, C., Botella, L. M., Marchuk, D. A., Vary, C., & Bernabéu, C. (1998) · Blood · doi:10.1182/blood.v92.12.4677 · Cited by 111
Bourdeau, A., Faughnan, M. E., McDonald, M., Paterson, A. D., Wanless, I. R., & Letarte, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64673-1 · Cited by 110
Goumans, M., Zwijsen, A., van Rooijen, M. A., Huylebroeck, D., Roelen, B. A. J., & Mummery, C. L. (1999) · Development · doi:10.1242/dev.126.16.3473 · Cited by 110
Rennebeck, G., Kleymenova, E., Anderson, R., Yeung, R. S. W., Artzt, K., & Walker, C. L. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15629 · Cited by 107
Transforming growth factor beta signaling in adult cardiovascular diseases and repair
Doetschman, T., Barnett, J. V., Runyan, R. B., Camenisch, T. D., Heimark, R. L., Granzier, H. L. M., Conway, S. J., & Azhar, M. (2011) · Cell and Tissue Research · doi:10.1007/s00441-011-1241-3 · Cited by 104
Gomez, D. A., Coyet, A., Ollivier, V., Jeunemaı̂tre, X., Jondeau, G., Michel, J., & Vranckx, R. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq291 · Cited by 99
Papetti, M., Shujath, J., Riley, K. N., & Herman, I. M. (2003) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-0291 · Cited by 96
Lipid signaling in embryo implantation
Wang, H., & Dey, S. K. (2004) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2004.09.013 · Cited by 94
G enetically A ltered M ouse M odels: the G ood, the B ad, and the U gly
Thyagarajan, T., Totey, S. M., Danton, M. J. S., & Kulkarni, A. B. (2003) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130301400302 · Cited by 93
Gorham, J. D., Lin, J. T., Sung, J. L., Rudner, L. A., & French, M. A. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.10.6413 · Cited by 89
Mutations of TGFß signaling molecules in human disease
Harradine, K. A., & Akhurst, R. J. (2006) · Annals of Medicine · doi:10.1080/07853890600919911 · Cited by 87
Self-citationModelling neuroinflammatory phenotypes in vivo.
Buckwalter, M. S., & Wyss‐Coray, T. (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-10 · Cited by 86
Coppen, S. R., Severs, N. J., & Gourdie, R. G. (1999) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1999)24:1/2 · Cited by 191
Strain dependency of TGF?1 function during embryogenesis
Kallapur, S. G., Ormsby, I., & Doetschman, T. (1999) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199904)52:4 · Cited by 84
Yao, Y. (2018) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x18801467 · Cited by 84
Gralinski, L. E., Menachery, V. D., Morgan, A. P., Totura, A. L., Beall, A. E., Kocher, J., Plante, J. A., Harrison-Shostak, D. C., Schäfer, A., de Villena, F. P., et al. (2017) · G3 Genes Genomes Genetics · doi:10.1534/g3.117.041434 · Cited by 79
Ingman, W. V., Robker, R. L., Woittiez, K. J., & Robertson, S. A. (2005) · Endocrinology · doi:10.1210/en.2005-1189 · Cited by 75
Transforming Growth Factor-β in Renal Disease
Bitzer, M., Sterzel, R. B., & Böttinger, E. P. (1998) · Kidney & Blood Pressure Research · doi:10.1159/000025837 · Cited by 75
Sprunger, L. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.3.471 · Cited by 72
Benzinou, M., Clermont, F. F., Letteboer, T. G. W., Kim, J.-H., Espejel, S., Harradine, K. A., Arbelaez, J., Luu, M. T., Roy, R., Quigley, D. A., et al. (2012) · Nature Communications · doi:10.1038/ncomms1633 · Cited by 69
Self-citationBeta 2-microglobulin-deficient background ameliorates lethal phenotype of the TGF-beta 1 null mouse.
Kobayashi, S., Yoshida, K., Ward, J. M., Letterio, J. J., Longenecker, G., Yaswen, L. R., Mittleman, B. B., Mozes, E., Roberts, A. B., Karlsson, S., et al. (1999) · PubMed · Cited by 65
TGFβ1 and TGFβ3 are partially redundant effectors in brain vascular morphogenesis
Mu, Z., Yang, Z., Yu, D., Zhao, Z., & Munger, J. S. (2008) · Mechanisms of Development · doi:10.1016/j.mod.2008.01.003 · Cited by 64
Pericytic Laminin Maintains Blood-Brain Barrier Integrity in an Age-Dependent Manner
Gautam, J., Cao, Y., & Yao, Y. (2019) · Translational Stroke Research · doi:10.1007/s12975-019-00709-8 · Cited by 60
Kim, J.-H., Peacock, M. R., George, S. C., & Hughes, C. C. W. (2012) · Angiogenesis · doi:10.1007/s10456-012-9277-x · Cited by 60
β2-Microglobulin-Deficient Background Ameliorates Lethal Phenotype of the TGF-β1 Null Mouse
Kobayashi, S., Yoshida, K., Ward, J. M., Letterio, J. J., Longenecker, G., Yaswen, L. R., Mittleman, B. B., Mozes, E., Roberts, A. B., Karlsson, S., et al. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.7.4013 · Cited by 66
Progesterone receptor requires a co-chaperone for signalling in uterine biology and implantation
Tranguch, S. L., Smith, D. F., & Dey, S. K. (2006) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)60655-4 · Cited by 53
“Gene‐Swap Knock‐in” Cassette in Mice to Study Allelic Differences in Human Genes
Nebert, D. W., Dalton, T. P., Stuart, G. W., & Carvan, M. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06876.x · Cited by 53
Factors in the Genetic Background Suppress theEngrailed-1Cerebellar Phenotype
Bilovocky, N. A., Romito‐DiGiacomo, R. R., Murcia, C. L., Maricich, S. M., & Herrup, K. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05105.2003 · Cited by 53
Frutkin, A. D., Shi, H., Otsuka, G., Levéen, P., Karlsson, S., & Dichek, D. A. (2006) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.06.067 · Cited by 53
Ingman, W. V., & Robertson, S. A. (2008) · Biology of Reproduction · doi:10.1095/biolreprod.107.067272 · Cited by 52
Lemos, M. C., Harding, B., Reed, A. J., Jeyabalan, J., Walls, G. V., Bowl, M. R., Sharpe, J. A., Wedden, S. E., Moss, J. E., Ross, A., et al. (2009) · Journal of Endocrinology · doi:10.1677/joe-09-0124 · Cited by 51
TGF-β Knockout and Dominant-Negative Receptor Transgenic Mice
Letterio, J. J., & Böttinger, E. P. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057365 · Cited by 51
Influence of Genetic Background on Knockout Mouse Phenotypes
Sanford, L. P., Kallapur, S. G., Ormsby, I., & Doetschman, T. (2003) · Humana Press eBooks · doi:10.1385/1-59259-220-1:217 · Cited by 49
Pratiwi, R., Fletcher, L. M., Pyper, W. R., Do, K.-A., Crawford, D. H., Powell, L. W., & Jazwinska, E. C. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80161-5 · Cited by 49
Accili, D., Nakae, J., Kim, J. J., Park, B. C., & Rother, K. I. (1999) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.1999.12.4.475 · Cited by 49
Chandler, C. H., Chari, S., Kowalski, A., Choi, L., Tack, D. C., DeNieu, M., Pitchers, W., Sonnenschein, A., Marvin, L., Hummel, K., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1007075 · Cited by 48
Kawasaki, K., Freimuth, J., Meyer, D. S., Lee, M. M., Tochimoto-Okamoto, A., Benzinou, M., Clermont, F. F., Wu, G., Roy, R., Letteboer, T. G. W., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318761111 · Cited by 47
Self-citationPhysiological consequences of β-adrenergic receptor disruption
Rohrer, D. K. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050278 · Cited by 44
Embryonic Fibroblasts from Mice Lacking Tgif Were Defective in Cell Cycling
Mar, L., & Hoodless, P. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02156-05 · Cited by 39
Genetic modifiers interact with maternal determinants in vascular development of Tgfb1(-/-) mice.
Tang, Y., McKinnon, M., Leong, L., Rusholme, S., Wang, S., & Akhurst, R. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg164 · Cited by 39
Wiede, F., Chew, S., van Vliet, C., Poulton, I. J., Kyparissoudis, K., Sasmono, R. T., Loh, K., Tremblay, M. L., Godfrey, D. I., Sims, N. A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036703 · Cited by 38
Role of TGF-? in immune-evasion of cancer
Beck, C., Schreiber, H. W., & Rowley, D. A. (2001) · Microscopy Research and Technique · doi:10.1002/1097-0029(20010215)52:4 · Cited by 105
A major role of TGF-β1 in the homing capacities of murine hematopoietic stem cell/progenitors
Capron, C., Lacout, C., Lécluse, Y., Jalbert, V., Chagraoui, H., Charrier, S., Galy, A. H. M., Griscelli, A. B., Cramer, E. M., & Vainchenker, W. (2010) · Blood · doi:10.1182/blood-2009-05-221093 · Cited by 37
Inflammation and TGFβ1: Lessons from the TGFβ1 null mouse
Kulkarni, A. B., & Karlsson, S. (1997) · Research in Immunology · doi:10.1016/s0923-2494(97)82669-7 · Cited by 37
Rosendahl, A. (2003) · International Immunology · doi:10.1093/intimm/dxg139 · Cited by 34
SMAD6-deficiency in human genetic disorders
Luyckx, I., Verstraeten, A., Goumans, M., & Loeys, B. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00338-5 · Cited by 35
The Roles of Smad2 and Smad3 in the Development of Chemically Induced Skin Tumors in Mice
Tannehill‐Gregg, S. H., Kusewitt, D. F., Rosol, T. J., & Weinstein, M. B. (2004) · Veterinary Pathology · doi:10.1354/vp.41-3-278 · Cited by 31
Goumans, M., Oostwaard, D. W., Wianny, F., Savatier, P., Zwijsen, A., & Mummery, C. L. (1998) · Differentiation · doi:10.1046/j.1432-0436.1998.6330101.x · Cited by 30
Hhex and Cer1 Mediate the Sox17 Pathway for Cardiac Mesoderm Formation in Embryonic Stem Cells
Liu, Y., Kaneda, R., Leja, T., Subkhankulova, T., Tolmachov, O. E., Minchiotti, G., Schwartz, R. J., Barahona, M., & Schneider, M. D. (2014) · Stem Cells · doi:10.1002/stem.1695 · Cited by 29
Uno, S., Endo, K., Ishida, Y., Tateno, C., Makishima, M., Yoshizato, K., & Nebert, D. W. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.03.001 · Cited by 29
Ohno, Y., Tanase, H., Nabika, T., Otsuka, K., Sasaki, T., Suzawa, T., Morii, T., Yamori, Y., & Saruta, T. (2000) · Genetics · doi:10.1093/genetics/155.2.785 · Cited by 28
Transforming growth factor beta 1 may regulate the stability of mature myelin sheaths
Day, W. A., Koishi, K., & McLennan, I. S. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00308-x · Cited by 27
Tang, Y., Lee, K. S., Yang, H., Logan, D. W., Wang, S., McKinnon, M. L., Holt, L. J., Condie, A., Luu, M. T., & Akhurst, R. J. (2004) · Genomics · doi:10.1016/j.ygeno.2004.09.003 · Cited by 26
Self-citationRole of TGF-β in Vascular Development and Vascular Reactivity
Perrella, M. A., Jain, M. K., & Lee, M.-E. (1998) · Mineral and Electrolyte Metabolism · doi:10.1159/000057361 · Cited by 27
Kobayashi, R., Terakawa, J., Kato, Y., Azimi, S., Inoue, N., Ohmori, Y., & Hondo, E. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.03.011 · Cited by 26
Miura, T., & Shiota, K. (2000) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(200003)217:3 · Cited by 115
Wu, B. X., Li, A., Lei, L., Kaneko, S., Wallace, C. H., Li, X., & Li, Z. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.797613 · Cited by 24
CYTOCHROME P450 KNOCKOUT MICE: NEW TOXICOLOGICAL MODELS
McKinnon, R. A., & Nebert, D. W. (1998) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1998.tb02153.x · Cited by 22
What do polymorphisms tell us about the mechanisms of COPD?
Li, Y., Cho, M. H., & Zhou, X. (2017) · Clinical Science · doi:10.1042/cs20160718 · Cited by 20
Probing Human Cardiovascular Congenital Disease Using Transgenic Mouse Models
Snider, P. L., & Conway, S. J. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00003-0 · Cited by 20
Characterization of ? cells developed in vitro from rat embryonic pancreatic epithelium
Miralles, F., Serup, P., Cluzeaud, F., Vewalle, A., Czernichow, P., & Scharfmann, R. (1999) · Developmental Dynamics · doi:10.1002/(sici)1097-0177(199902)214:2 · Cited by 41
Metadata
- Authors
- Bonyadi, M., Rusholme, S. A. B., Cousins, F. M., Su, H. C., Biron, C. A., Farrall, M., & Akhurst, R. J.
- Affiliations
- University of Glasgow (GB)
- University of Oxford (GB)
- Brown University (US)
- Centre for Human Genetics (GB)
- Corresponding author
- Akhurst, Rosemary J.
- Venue
- Nature Genetics
- Published
- 1997-02
- Volume
- 15
- Issue
- 2
- Pages
- 207-211
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2064113953
- Cited by
- 166
- References
- 34
- Citations by year
- 2025: 3 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 2 · 2018: 3 · 2017: 7 · 2016: 4 · 2015: 2 · 2014: 5 · 2013: 2 · 2012: 7
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Keywords
- TGF-β1, embryonic lethality, genetic modifiers, hereditary hemorrhagic telangiectasia, chromosome 5, genetic background, genome scan, mouse strains
- MeSH terms
- Animals, Chromosome Mapping, Crosses, Genetic, Fetal Death, Embryonic and Fetal Development, Genes, Lethal, Hematopoiesis, Mice, Inbred C57BL, Phenotype, Yolk Sac, Transforming Growth Factor beta, Mice, Knockout, Microsatellite Repeats, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review